Literature DB >> 12198968

Purification of icariin from the extract of Epimedium segittatum using high-speed counter-current chromatography.

Qizhen Du1, Ming Xia, Yoichiro Ito.   

Abstract

Icariin was purified from the extract of Epimedium segittatum by high-speed counter-current chromatography with a two-phase solvent system composed of n-hexane-n-butanol-methanol-water (1:4:2:6, v/v). We used two multilayer coil planet centrifuges with different capacities. A 300 mg amount of the extract was separated using a semipreparative instrument equipped with a 230-ml capacity column to yield 103 mg of icariin at 86.2% purity. An 8 g amount of the extract was separated with a large preparative instrument equipped with a 2460-ml capacity column to produce 2.45 g of icariin at 85.7% purity. From these fractions over 98% pure icariin was obtained by recrystallization with water.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12198968     DOI: 10.1016/s0021-9673(02)00538-1

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  4 in total

1.  Antioxidative protective effect of icariin on the FeSO4/H 2O 2-damaged human sperm based on confocal raman micro-spectroscopy.

Authors:  Zhan-Sen Huang; Heng-Jun Xiao; Tao Qi; Zhi-Ming Hu; Hao Li; Di-Ling Chen; Ya-Lin Xu; Jun Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-10-16

2.  Influence of the mixture of Epimedii Herba and Ginkgo Folium extracts on the coronary flow of isolated hearts in rats.

Authors:  Dongfang Zhang; Changji Yuan; Zheng Zhu; Xin Jin; Lihong Li
Journal:  Pharmacogn Mag       Date:  2013-10       Impact factor: 1.085

3.  A novel antagonistic role of natural compound icariin on neurotoxicity of amyloid β peptide.

Authors:  Jianhui Liu; Zixuan Liu; Yonglan Zhang; Fei Yin
Journal:  Indian J Med Res       Date:  2015-08       Impact factor: 2.375

Review 4.  Icariin, an Up-and-Coming Bioactive Compound Against Neurological Diseases: Network Pharmacology-Based Study and Literature Review.

Authors:  Shuangqiu Wang; Jiarui Ma; Yanqi Zeng; Guowei Zhou; Yuxuan Wang; Wenjuan Zhou; Xiaohe Sun; Minghua Wu
Journal:  Drug Des Devel Ther       Date:  2021-08-20       Impact factor: 4.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.